{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/04/17/3276475/0/en/Cardiff-Oncology-Presents-Preclinical-Data-on-its-PLK1-Inhibitor-Onvansertib-in-Combination-with-a-HER2-Targeted-ADC-at-the-2026-AACR-Annual-Meeting.html", "message": "News view counter 669551 successfully enlarged"}